The top five OA-related KEGG pathways with tomatidine-target genes include MAPK signaling, neurotrophin signaling, colorectal cancer, renal cell carcinoma, and long-term potentiation pathways (Table 1). This evidence concerns the gene BDNF and hereditary clear cell renal cell carcinoma.